High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.8M
$3,772,798
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $17,506 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-06 | $279,033 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $17,003 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $179,283 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $34,228 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $68,639 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $17,183 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $51,708 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $50,176 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $69,472 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $34,825 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $34,935 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to CoverΔOwn -11.3%
|
2026-03-02 | $505,389 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $94,460 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $44,045 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Other
|
2025-12-02 | $1,050,052Large | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Equity Compensation
|
2025-12-02 | $0 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $47,695 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $182,524 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $234,516 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $202,847 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $411,559 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $68,994 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $138,276 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $184,901 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $149,338 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $278,329 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $140,505 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $141,084 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $94,344 | S | Form 4 |